Circulating epigenetic and epitranscriptomic biomarkers identify EGFR status, predict TKI response and reveal therapeutic vulnerabilities in NSCLC

D Dorian Espi-Bastien J Judith Raimbourg G Gwenola Bougras-Cartron A Arulraj Nadaradjane S Séverine Blondeau G Guillaume Dupas B Bertrand Volard A Armelle Lefrançois F Fabien Gautier J Julien Mazières (Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier, Toulouse, France) F Franck Morin O Olivier Molinier F Fabrice Barlesi E Elodie Amour M Mathilde Dupé P Pierre-Francois Cartron

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 20, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (16)

D

Dorian Espi-Bastien

J

Judith Raimbourg

G

Gwenola Bougras-Cartron

A

Arulraj Nadaradjane

S

Séverine Blondeau

G

Guillaume Dupas

B

Bertrand Volard

A

Armelle Lefrançois

F

Fabien Gautier

J

Julien Mazières

Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier, Toulouse, France

F

Franck Morin

O

Olivier Molinier

F

Fabrice Barlesi

E

Elodie Amour

M

Mathilde Dupé

P

Pierre-Francois Cartron